For the Love of Lipids: Cholesterol Management to Reduce the Risk of Atherosclerotic Cardiovascular Disease

The guideline governing the management of blood cholesterol to reduce cardiovascular risk was recently revised at the end of 2018. Several critical changes were made to the guideline, including the identification of high risk and very high-risk factors, restructuring of patient groups in which to consider drug therapy, revised therapeutic targets, and incorporation of newer non-statin drugs to the clinical armamentarium. It is imperative to disseminate these updates to healthcare practitioners, so that they can provide evidence-based, patient-centered care as members of an interdisciplinary team.